methylprednisolone has been researched along with Lymphoma, T Cell, Peripheral in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gutierrez, A; Rodriguez, J | 1 |
| Fisher, RI; LeBlanc, M; Mahadevan, D; Miller, TP; Persky, DO; Spier, CM; Unger, JM; Young, F | 1 |
| al-Farsi, K; Crump, M; Keating, A; Kuruvilla, J; Puig, N; Seshadri, T; Wang, L | 1 |
| Hanaoka, R; Ide, H; Inokuma, S; Kasama, T; Negishi, M | 1 |
| Culligan, DJ; Johnston, PW; Milner, BJ; Mittal, S | 1 |
| Kotani, T; Nakamura, Y; Ueda, M; Yamaguchi, M | 1 |
| Arkenau, HT; Chau, I; Chong, G; Cunningham, D; Horwich, A; Matutes, E; Norman, A; Sirohi, B; Watkins, D; Wotherspoon, A | 1 |
| Ebina, K; Kowada, M; Mineura, K; Sasajima, T; Sawataishi, J; Sugawara, A | 1 |
1 review(s) available for methylprednisolone and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Primary central nervous system involvement of the so called 'peripheral T-cell lymphoma'. Report of a case and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Basal Ganglia; Biopsy; Brain Neoplasms; Combined Modality Therapy; Dexamethasone; Diagnosis, Differential; Female; Humans; Immunophenotyping; Life Tables; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Methotrexate; Methylprednisolone; Middle Aged; Survival Analysis; Vincristine | 1993 |
1 trial(s) available for methylprednisolone and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cisplatin; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Middle Aged; Neoplasm Staging; Treatment Outcome; Young Adult | 2013 |
6 other study(ies) available for methylprednisolone and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Value of frontline autologous stem-cell transplantation in peripheral T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, T-Cell, Peripheral; Methylprednisolone; Peripheral Blood Stem Cell Transplantation; Prednisone; Vincristine | 2008 |
Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult | 2013 |
Peripheral T cell lymphoma-associated hemophagocytic syndrome in a patient with human adjuvant disease.
Topics: Adjuvants, Immunologic; Arthritis, Experimental; Blood Transfusion; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Histiocytosis, Non-Langerhans-Cell; Humans; Lymph Nodes; Lymphoma, T-Cell, Peripheral; Methylprednisolone; Middle Aged; Spleen | 2003 |
A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Crohn Disease; Cytarabine; Epirubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Liver; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Male; Methylprednisolone; Pentostatin; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Spleen; Transplantation, Homologous; Vidarabine | 2006 |
Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Neoplasms, Second Primary; Prednisone; Recurrence; Remission Induction; Time Factors; Vidarabine; Vincristine | 2006 |
Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Middle Aged; Prognosis; Remission Induction; Treatment Outcome | 2007 |